Enovix: A Worthy Buy For Asymmetric Upside (Archive)

This 5-Minute Pitch was originally published on Seeking Alpha before the launch of the Hunting Alphas website. It is shared here to showcase my previous work and track record. New 5-Minute Pitches published on this site will not be disseminated anywhere else.

Elevator Pitch

• Enovix Corporation's revenue scale up is progressing slower than expected due to guidance misses and lower-than-expected throughput in its first high-volume manufacturing line.
• But Enovix is progressing well on smartphone customer engagements, scaling up manufacturing operations, and on battery product R&D milestones, with no delays; a respectable achievement.
• Valuations remain optically high for this early-stage business, but I think it is difficult to assess it on traditional valuation metrics.
• Relative technicals on ENVX vs. the S&P 500 are bullish, despite high volatility in the stock.
• Risks to the buy thesis include faltering execution, making milestones' progress a key monitorable. I am also tracking the short interest in the stock. I think it is bullish that this has reduced since Q3 FY 2024.

Read the full article here.